SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-008939
Filing Date
2024-01-30
Accepted
2024-01-30 17:00:20
Documents
12
Period of Report
2024-01-26
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cmra-20240126.htm   iXBRL 8-K 69044
  Complete submission text file 0000950170-24-008939.txt   231186

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cmra-20240126.xsd EX-101.SCH 55605
13 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20240126_htm.xml XML 6427
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 24579005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)